Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of underlying ...
A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get the ...
The tax brackets you fall into determine how much you owe the IRS at tax time. For tax year 2024 (filing in 2025), there are seven brackets: 10%, 12%, 22%, 24%, 32%, 35% and 37%. That will remain the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback